Clinical trial
A Prospective Randomized Controlled Study on 14-day Short-term Spinal Cord Stimulation Minimally Invasive Intervention for Patients With Refractory Diabetic Foot Neuropathic Pain
NCT07740707 is registered in ClinicalTrials.gov with Nanchong Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Controlled Study on 14-day Short-term Spinal Cord Stimulation Minimally Invasive Intervention for Patients With Refractory Diabetic Foot Neuropathic Pain
- Lead sponsor
- Nanchong Central Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- March 1, 2027
- Enrollment
- 88 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
refractory diabetic foot neuropathic pain